Enable Medicine

Enable Medicine offers an advanced AI-driven cloud platform that integrates high-resolution single-cell data, spatial biology information, and clinical metadata into comprehensive biological atlases. These atlases are used by biopharma companies and academic researchers to accelerate drug discovery by enabling target identification, patient stratification, indication selection, biomarker development, mechanism-of-action studies, and trial design. The company’s technology has been validated through partnerships such as Ennovate Pharma SAS (with General Inception), which has led to the identification of promising new drug targets in autoimmune/inflammatory disease non-responder populations.